Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy [NA]

View source ↗

Summary

Update on a clinical trial evaluating endoscopic gastric mucosal ablation as a primary therapy for obesity; the study is sponsored by Erbe Elektromedizin GmbH a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erbe Elektromedizin GmbH | Conditions: Obesity, Adiposity | NA | Status: ACTIVE_NOT_RECRUITING